Back to Search
HAROLD MOSES, MD
MD
Neurology Physician
NPI: 1417031535IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
MD29511(TN)
CMS Specialties
PrimaryNEUROLOGY
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis.
PMID 18694542·Curr Med Res Opin·2008
8-other
An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents.
PMID 11437685·BioDrugs·2001
6-review
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.
PMID 19086032·J Cell Physiol·2009
7-preclinical
Funding of Parkinson research from industry and US federal and foundation sources.
PMID 19133662·Mov Disord·2009
8-other
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
PMID 19451693·J Clin Invest·2009
8-other
GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.
PMID 19435821·Mol Cancer Res·2009
7-preclinical
TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung.
PMID 18321928·Eur Respir J·2008
7-preclinical
Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
PMID 18339861·Cancer Res·2008
7-preclinical
Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells.
PMID 18676846·Cancer Res·2008
8-other
Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1.
PMID 18729074·J Cell Biochem·2008
8-other
Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?
PMID 19010878·Cancer Res·2008
6-review
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
PMID 18167337·Cancer Cell·2008
7-preclinical
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
PMID 18922968·Mol Cancer Res·2008
7-preclinical
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
PMID 17495323·Cancer Res·2007
7-preclinical
Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.
PMID 17495520·Cancer Biol Ther·2007
8-other
Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
PMID 17505536·Int J Biol Sci·2007
7-preclinical
Signaling pathways regulating TC21-induced tumorigenesis.
PMID 17656362·J Biol Chem·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 TVC
NASHVILLE, TN 37232 - Phone
- (615) 322-3000
Quick Facts
- NPI
- 1417031535
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile